Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
Boschetti G, Laidet M, Moussata D, Stefanescu C, Roblin X, Phelip G, Cotte E, Passot G, Francois Y, Drai J, Del Tedesco E, Bouhnik Y, Flourie B, Nancey S. Boschetti G, et al. Among authors: drai j. Am J Gastroenterol. 2015 Jun;110(6):865-72. doi: 10.1038/ajg.2015.30. Epub 2015 Mar 17. Am J Gastroenterol. 2015. PMID: 25781366
Response to Dai et al.
Boschetti G, Drai J, Flourié B, Nancey S. Boschetti G, et al. Among authors: drai j. Am J Gastroenterol. 2015 Aug;110(8):1242. doi: 10.1038/ajg.2015.199. Am J Gastroenterol. 2015. PMID: 26263365 No abstract available.
Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S, Boschetti G, Moussata D, Cotte E, Peyras J, Cuerq C, Haybrard J, Charlois AL, Mialon A, Chauvenet M, Stroeymeyt K, Kaiserlian D, Drai J, Flourié B. Nancey S, et al. Among authors: drai j. Inflamm Bowel Dis. 2013 Apr;19(5):1043-52. doi: 10.1097/MIB.0b013e3182807577. Inflamm Bowel Dis. 2013. PMID: 23511035
Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay.
Vors C, Joumard-Cubizolles L, Lecomte M, Combe E, Ouchchane L, Drai J, Raynal K, Joffre F, Meiller L, Le Barz M, Gaborit P, Caille A, Sothier M, Domingues-Faria C, Blot A, Wauquier A, Blond E, Sauvinet V, Gésan-Guiziou G, Bodin JP, Moulin P, Cheillan D, Vidal H, Morio B, Cotte E, Morel-Laporte F, Laville M, Bernalier-Donadille A, Lambert-Porcheron S, Malpuech-Brugère C, Michalski MC. Vors C, et al. Among authors: drai j. Gut. 2020 Mar;69(3):487-501. doi: 10.1136/gutjnl-2018-318155. Epub 2019 Jun 12. Gut. 2020. PMID: 31189655 Free PMC article. Clinical Trial.
Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women.
Le Barz M, Vors C, Combe E, Joumard-Cubizolles L, Lecomte M, Joffre F, Trauchessec M, Pesenti S, Loizon E, Breyton AE, Meugnier E, Bertrand K, Drai J, Robert C, Durand A, Cuerq C, Gaborit P, Leconte N, Bernalier-Donadille A, Cotte E, Laville M, Lambert-Porcheron S, Ouchchane L, Vidal H, Malpuech-Brugère C, Cheillan D, Michalski MC. Le Barz M, et al. Among authors: drai j. JCI Insight. 2021 May 24;6(10):e146161. doi: 10.1172/jci.insight.146161. JCI Insight. 2021. PMID: 33857018 Free PMC article. Clinical Trial.
[Aseptic process validation and stability study of an injectable preparation of fructose (5%)-glycerol (10%) as part of a hospital clinical research program on endoscopic curative treatment for early epithelial neoplastic lesions of the gastrointestinal tract].
Tall ML, Salmon D, Diouf E, Drai J, Filali S, Lépilliez V, Pioche M, Laleye D, Dhelens C, Ponchon T, Pivot C, Pirot F. Tall ML, et al. Among authors: drai j. Ann Pharm Fr. 2015 Mar;73(2):139-49. doi: 10.1016/j.pharma.2014.09.002. Epub 2014 Oct 16. Ann Pharm Fr. 2015. PMID: 25745945 French.
94 results